Rite Aid Corporation (NYSE:RAD) has announced that it would be donating $1.8 million to KidCents Charities, in recognition of customers who get their flu shots this season. As such, a total of 360 KidCents centers would receive a grant of $5,000, so as to improve the overall health and well being of children in their communities. KidCents charities tend to spread hope in their respective communities.
Ken Martindale, the CEO of RAD, claimed that hope is more contagious than flu and that is what KidCents is working to spread. He stated that this was a part of their mission at Rite Aid, to improve the lives of children and offer them a better future. Mr. Martindale also stated that this donation was on behalf of all Rite Aid customers, who received a flu shot this season. He claimed that donations like this help their partner charities in continuing to make a difference.
KidCents had been developed by RAD, so as to provide its customers with an opportunity to do more for children. Rite Aid customers are encouraged to round up their purchases to the nearest dollar, with the extra cash going to one of the 360 non-profit partner organizations, including KidCents. It should be noted here that since its inception, in 2001, the company has donated over $27 million to non-profit organizations. This is in addition to, raising over $75 million, for Children’s Hospitals, through efforts with customers, partners and associates.
Recently, the company announced that through December 7, 2016, it would be helping its senior customers, in selecting the right prescription drug plan, for themselves. This is being done as part of their annual enrollment of Medicare Part D. Customers can make use of RAD’s Medicare Advisor tool, to compare the three lowest priced drugs, for their condition. The resources can be accessed for free at any Rite Aid retail location or online.
Rite Aid Corporation (NYSE:RAD) had a trade volume of 18.29 million and lost 3.14% of its share value, during the October 26 trading session, to close at $6.79 per share.